XML 21 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]    
REVENUES $ 4,027 $ 256
OPERATING EXPENSES:    
Research and development 996,487 915,818
General and administrative 2,711,145 3,047,360
Impairment loss 52,363
Total Operating Expenses 3,707,632 4,015,541
LOSS FROM OPERATIONS (3,703,605) (4,015,285)
OTHER INCOME:    
Interest income 157,557 46,526
Realized gain on short-term investments 121,765 20,662
Total other income 279,322 67,188
NET LOSS (3,424,283) (3,948,097)
Net loss of subsidiary attributable to noncontrolling interest 6,086
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS (3,418,197) (3,948,097)
COMPREHENSIVE LOSS:    
Net loss (3,424,283) (3,948,097)
Other comprehensive income:    
Unrealized (loss) income on short-term investments (84,092) 95,785
Comprehensive loss $ (3,508,375) $ (3,852,312)
NET LOSS PER COMMON SHARE ATTRIBUTABLE TO COMMON SHAREHOLDERS:    
Basic (in Dollars per share) $ (1.92) $ (3.9)
Diluted (in Dollars per share) $ (1.92) $ (3.9)
WEIGHTED AVERAGE COMMON SHARE OUTSTANDING:    
Basic (in Shares) 1,777,451 987,938
Diluted (in Shares) 1,777,451 987,938